Inner Mongolia Yili Industrial Group has been granted a patent for a new use of Lactobacillus paracasei subsp. paracasei K56 in regulating gastrointestinal flora balance. The strain has been shown to promote the growth of beneficial bacteria, suppress harmful bacteria, and withstand gastrointestinal stress. It is also safe for consumption and can be used in food processing. GlobalData’s report on Inner Mongolia Yili Industrial Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inner Mongolia Yili Industrial Group, lactobacilli-based drug compositions was a key innovation area identified from patents. Inner Mongolia Yili Industrial Group's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for a method to regulate gastrointestinal flora
A recently granted patent (Publication Number: US11666613B2) discloses a method for regulating gastrointestinal flora by administering a composition containing Lactobacillus paracasei subsp. paracasei to a subject. The composition increases the amount of Bifidobacterium, Lactobacillus, or both in the intestine, while suppressing the amount of Desulfovibrio, Enterobacter, or both, as well as Helicobacter, Escherichia-Shigella, or both. The Lactobacillus paracasei subsp. paracasei present in the composition is in the range of 1.0×103 CFU to 5.0×108 CFU/kg body weight/day.
The method described in the patent involves administering the composition, which can be in the form of a solid or liquid bacterial preparation, to regulate the gastrointestinal flora of a subject. The composition can be included in various forms such as a food composition, a feed composition, or a pharmaceutical composition. In particular, the patent mentions the use of the composition in food products like fermented dairy products, cheese, dairy beverages, solid beverages, or milk powder.
The patent also provides specific dosage ranges for the administration of Lactobacillus paracasei subsp. paracasei. The effective amount of the bacteria to be administered to the subject is in the range of 1.0×103 CFU to 5.0×108 CFU/kg body weight/day. Another claim specifies a narrower range of 1.0×104 CFU to 5.0×108 CFU/kg body weight/day.
Overall, this granted patent discloses a method for regulating gastrointestinal flora by administering a composition containing Lactobacillus paracasei subsp. paracasei. The composition increases beneficial bacteria like Bifidobacterium and Lactobacillus while suppressing harmful bacteria like Desulfovibrio, Enterobacter, Helicobacter, and Escherichia-Shigella. The patent provides dosage ranges and mentions the use of the composition in various forms, including food products.
To know more about GlobalData’s detailed insights on Inner Mongolia Yili Industrial Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
